ArticleProceedings of the National Academy of Sciences of the United States of America2003

IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.

Stephane Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.